factual

What is the scope of 'Confidential Information' covered by the Dermani Medspa agreement?

Dermani_Medspa Franchise · 2025 FDD

Answer from 2025 FDD Document

6. CONFIDENTIAL INFORMATION

  • 6.1. We possess (and will continue to develop and acquire) certain Confidential Information, some of which constitutes trade secrets under applicable law, relating to developing and operating Franchised Businesses and Medspas, including:
    • 6.1.1. site selection and territorial criteria;
    • 6.1.2. training and operations materials and manuals;
    • 6.1.3. methods, formats, specifications, standards, systems, procedures, sales and marketing techniques, knowledge, and experience used in developing and managing Medspas and offering or selling certain medspa products or services;
    • 6.1.4. marketing and advertising programs for Medspas;
    • 6.1.5. knowledge of, specifications for, and suppliers of Operating Assets, and other products and services;
    • 6.1.6. any computer software or similar technology which is proprietary to us or the System, including, without limitation, digital passwords and identifications and any source code of, and data, reports, and other printed materials generated by, the software or similar technology;
    • 6.1.7. knowledge of the operating results and financial performance of Medspas and Franchised Businesses (subject to compliance with HIPAA and other requirements);
    • 6.1.8. graphic designs and related intellectual property; and
    • 6.1.9. any passwords or other digital identifications necessary to access the Manual on a Website.
  • 6.2. You acknowledge and agree that you will not acquire any interest in the Confidential Information by virtue of this Agreement or otherwise, other than the right to use it as we specify in operating the Franchised Business during this Agreement's Initial Term, and that the Confidential Information is proprietary and is disclosed to you only on the condition that you agree that you:
    • 6.2.1. will not use Confidential Information in any other business or capacity;
    • 6.2.2. will keep each item deemed to be part of Confidential Information absolutely confidential, both during the Initial Term and then thereafter for as long as the item is not generally known in the employment and/or health care industries;
    • 6.2.3. will not make unauthorized copies of any Confidential Information disclosed via electronic medium or in written or other tangible form; and
    • 6.2.4. will adopt and implement reasonable procedures to prevent unauthorized use or disclosure of Confidential Information, including restricting its disclosure to Franchised Business

Source: Item 23 — RECEIPTS (FDD pages 66–311)

What This Means (2025 FDD)

According to the 2025 Dermani Medspa FDD, the scope of confidential information is broad, covering various aspects of the franchise's operations and systems. It includes information, knowledge, and know-how related to Dermani Medspa, its business plans, franchised businesses, and the System, unless the franchisee can prove the information was already known to them lawfully or was public knowledge before disclosure. This means franchisees must treat almost all information they receive about running a Dermani Medspa as confidential.

The FDD specifies that confidential information includes site selection criteria, training materials, operational manuals, methods, formats, specifications, standards, systems, procedures, sales and marketing techniques, and knowledge used in developing and managing Medspas. It also extends to marketing and advertising programs, knowledge of suppliers for operating assets, proprietary computer software (including passwords and source code), operating results, financial performance of Medspas, graphic designs, and any digital identifications needed to access the manual online.

Dermani Medspa franchisees acknowledge they won't acquire any rights to the confidential information beyond using it to operate their franchise during the agreement term. They must not use the information in any other business, keep it strictly confidential during and after the term as long as it remains non-public, avoid unauthorized copies, and implement procedures to prevent unauthorized use or disclosure. This ensures that Dermani Medspa maintains control over its proprietary information and methods, protecting its competitive advantage.

Disclaimer: This information is extracted from the 2025 Franchise Disclosure Document and is provided for research purposes only. It does not constitute legal or financial advice. Consult with a franchise attorney before making any investment decisions.